Related Experiment Video
Updated: Nov 25, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Thyroid eye disease in New Zealand: interaction between ethnicity and smoking status
Lize Angelo1, Rachael Niederer2, Richard Hart3
1Second Year House Officer and Prospective PhD Student, University of Auckland, Auckland.
Aim:
This study was conducted to describe the epidemiology of thyroid eye disease (TED) in New Zealand.
Methods:
One hundred and sixty-one subjects with TED seen over a 14-year period in Auckland, from a combined ophthalmology-endocrinology clinic, had data extracted from clinical notes.
Results:
Median age at onset was 47.0±15.1 years and 77.6% were female. Crude yearly incidence of TED (per 1,000,000) was 12.6 in non-smokers and 67.3 in smokers (p<0.001). On univariate analysis, female gender, Māori ethnicity and smoking were associated with incidence of TED. On multivariate analysis, female gender and smoking status were associated with risk of TED, and the difference in ethnicity was explained by smoking status. Māori subjects with TED were more likely to be current smokers (72.7%) compared to European (39.2%), Pacific Peoples (33.3%), Asian (8.3%) and Other (12.5%). Māori ethnicity and current smokers were associated with a higher clinical activity score at presentation (p=0.049 and p=0.027).
Conclusion:
A strong association was demonstrated with female gender and smoking status and rate of TED. Māori have increased rates of TED; however, this difference was explained by smoking. Eliminating smoking would result in at least a 28.1% reduction in TED incidence in New Zealand.
More Related Videos
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
07:36Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Surveys